SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Generic: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Par Health USAManufacturer
ORALRoute
SITAGLIPTIN PHOSPHATEActive Substance
2025-06-04Original Approval
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is FDA application ANDA204144, sponsored by PH HEALTH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
COMPLETED SUICIDE
4 reports
2
DIZZINESS
4 reports
3
DRUG INEFFECTIVE
4 reports
4
PAIN IN EXTREMITY
4 reports
5
ABNORMAL DREAMS
3 reports
6
DIARRHOEA
3 reports
7
MALAISE
3 reports
8
NAUSEA
3 reports
9
SOMNOLENCE
3 reports
10
ANXIETY
2 reports